AGC Biologics is set to expand its Cell Line Development Centre of Excellence through a partnership with ATUM for integrating the Leap-In transposase expression platform into its services. With this ...
Samsung Biologics said Monday it has launched in-house master cell bank production and vector construction services, strengthening its contract development orga ...
The "Cell Line Characterization and Cell Line Development Market Industry Trends and Global Forecasts to 2035: Distribution by Source of Cell Line / Expression System, Application of Cell Line, ...
EZ-editor™ platform, large-scale cell resources, and standardised workflows support faster and more reliable knockout ...
BOSTON, March 17, 2026 (GLOBE NEWSWIRE)-- Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced a cell line development partnership with Score ...
New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...
The global cell line development market is growing rapidly; it is estimated to be worth USD 1.01 billion in 2023 and is expected to reach USD 4.5 billion by 2035. It is anticipated to grow at a higher ...
Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...
DURHAM, N.C., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (SCPX) (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract ...
Synthetic bio company Asimov agreed to collaborate with Cytiva to provide customers with an integrated offering for optimized biologics production. Access includes Asimov’s CHO Edge cell line ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results